Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy

BACKGROUND: Treatment remains uncertain for IgA nephropathy patients with mild to moderate proteinuria, for whom anti-hypertensive medication or the RAS blocker is not applicable due to low blood pressure. TRIAL DESIGN: A double blinded randomized trial. METHODS: The anti-proteinuric effect of tacro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong-Chul, Chin, Ho Jun, Koo, Ho Suk, Kim, Suhnggwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747236/
https://www.ncbi.nlm.nih.gov/pubmed/23977072
http://dx.doi.org/10.1371/journal.pone.0071545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747236/
https://www.ncbi.nlm.nih.gov/pubmed/23977072
http://dx.doi.org/10.1371/journal.pone.0071545

Ejemplares similares